Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gemcitabine hydrochloride|DRUG: pegylated liposomal doxorubicin hydrochloride
Sponsor: Pharmatech Oncology